Abstract:BRD7, a novel bromodomain gene, is identified to be associated with nasopharyngeal carcinoma (NPC). Decreased or loss of expression of BRD7 was detected in NPC biopsies and cell lines. Overexpression of BRD7 could inhibit NPC cell growth and arrest cells in cell cycle by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathway, and downregulate the promoter activity of E2F3. In the present study, the subcellular localization of BRD7 was investigated. It was found that BRD7 was mainly localized in nucleus without distinct cell‐specific difference between COS7 and HNE1. Furthermore, a functional nuclear localization signal (NLS) sequence ranging from amino acid 65 to 96 was identified and characterized. The NLS is composed of a cluster of four bipartite nuclear targeting sequences, which are tightly linked and extremely overlapped. We found that whether the entire NLS or the four bipartite nuclear targeting sequences could respectively determine the nuclear import of green fluorescent protein (GFP). The most important is that NLS‐deleted BRD7 shifted the nuclear localization to be mostly in cytoplasm, and failed or reduced to negatively regulate the expression of cell cycle related molecules, cyclin D1 and E2F3, and cell cycle progression from G1 to S phase. In conclusion, NLS is an essential motif affecting BRD7 nuclear distribution, and the nuclear localization of BRD7 is critical for the expression of cell cycle related molecules and cell biological function. J. Cell. Biochem. 98: 920–930, 2006. © 2006 Wiley‐Liss, Inc.

Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.

The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain

Study the motif-bromodomain of BRD7 and identify a novel interaction protein with BRD7

Tumor suppressor bromodomain-containing protein 7 cooperates with Smads to promote transforming growth factor-β responses

Analysis of Bromodomain of BRD-7 Gene and Its Prokaryotic Expression.

BRD7 Suppresses Tumor Chemosensitivity to CHK1 Inhibitors by Inhibiting USP1-mediated Deubiquitination of CHK1

Solution Structure of Human Brg1 Bromodomain and Its Specific Binding to Acetylated Histone Tails.

BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.

BRD7, a Novel Bromodomain Gene, Inhibits G1–S Progression by Transcriptionally Regulating Some Important Molecules Involved in Ras/mek/erk and Rb/E2F Pathways

Screening of BRD7 Interacting Proteins by Yeast Two-Hybrid System

Structural Basis and Binding Properties of the Second Bromodomain of Brd4 with Acetylated Histone Tails.

Structural insight into CBP bromodomain-mediated recognition of acetylated histone H3K56ac.

Structural insight into the recognition of acetylated histone H3K56ac mediated by the bromodomain of CREB‐binding protein

Cloning and characterization of the BRD7 gene promoter.

BRD4 phosphorylation regulates the structure of chromatin nanodomains

Identification of Nuclear Localization Signal That Governs Nuclear Import of BRD7 and Its Essential Roles in Inhibiting Cell Cycle Progression

BRD2 is one of BRD7-interacting proteins and its over-expression could initiate apoptosis

Cloning and Functional Characterization of the Regulation Region of Human Brd7 Gene

A bromodomain-DNA interaction facilitates acetylation-dependent bivalent nucleosome recognition by the BET protein BRDT

Advances in BRD9 Protein Inhibitors

Chromatin acetylation associated BRD protein family